• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米技术提高难溶性抗高血压药物口服生物利用度的方法

Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs.

作者信息

Sharma Mayank, Sharma Rajesh, Jain Dinesh Kumar

机构信息

School of Pharmacy, Devi Ahilya Vishwavidyalaya, Indore, India.

College of Pharmacy, IPS Academy, Indore, India.

出版信息

Scientifica (Cairo). 2016;2016:8525679. doi: 10.1155/2016/8525679. Epub 2016 Apr 30.

DOI:10.1155/2016/8525679
PMID:27239378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4867069/
Abstract

Oral administration is the most convenient route among various routes of drug delivery as it offers high patient compliance. However, the poor aqueous solubility and poor enzymatic/metabolic stability of drugs are major limitations in successful oral drug delivery. There are several approaches to improve problems related to hydrophobic drugs. Among various approaches, nanotechnology based drug delivery system has potential to overcome the challenges associated with the oral route of administration. Novel drug delivery systems are available in many areas of medicine. The application of these systems in the treatment of hypertension continues to broaden. The present review focuses on various nanocarriers available in oral drug administration for improving solubility profile, dissolution, and consequently bioavailability of hydrophobic antihypertensive drugs.

摘要

口服给药是各种给药途径中最方便的途径,因为它具有很高的患者依从性。然而,药物的水溶性差以及酶促/代谢稳定性差是口服给药成功的主要限制因素。有几种方法可以改善与疏水性药物相关的问题。在各种方法中,基于纳米技术的药物递送系统有潜力克服与口服给药途径相关的挑战。新型药物递送系统在医学的许多领域都有应用。这些系统在高血压治疗中的应用不断扩大。本综述重点关注口服给药中可用的各种纳米载体,以改善疏水性抗高血压药物的溶解度、溶出度,从而提高其生物利用度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/88b36b32d583/SCIENTIFICA2016-8525679.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/eab01a035be5/SCIENTIFICA2016-8525679.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/18b787055609/SCIENTIFICA2016-8525679.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/88b36b32d583/SCIENTIFICA2016-8525679.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/eab01a035be5/SCIENTIFICA2016-8525679.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/18b787055609/SCIENTIFICA2016-8525679.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32a1/4867069/88b36b32d583/SCIENTIFICA2016-8525679.003.jpg

相似文献

1
Nanotechnology Based Approaches for Enhancing Oral Bioavailability of Poorly Water Soluble Antihypertensive Drugs.基于纳米技术提高难溶性抗高血压药物口服生物利用度的方法
Scientifica (Cairo). 2016;2016:8525679. doi: 10.1155/2016/8525679. Epub 2016 Apr 30.
2
Candesartan cilexetil loaded nanodelivery systems for improved oral bioavailability.用于提高口服生物利用度的坎地沙坦酯纳米递送系统。
Ther Deliv. 2017 Feb;8(2):79-88. doi: 10.4155/tde-2016-0063.
3
Lipid-Based Nanocarriers for Lymphatic Transportation.基于脂质的纳米载体用于淋巴递药
AAPS PharmSciTech. 2019 Jan 23;20(2):83. doi: 10.1208/s12249-019-1293-3.
4
Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.脂质纳米载体作为改善难溶性药物口服和黏膜给药剂型的选择。
Curr Med Chem. 2012;19(26):4495-510. doi: 10.2174/092986712803251584.
5
Diverse approaches for the enhancement of oral drug bioavailability.多种方法提高口服药物生物利用度。
Biopharm Drug Dispos. 2011 May;32(4):185-209. doi: 10.1002/bdd.750. Epub 2011 Apr 7.
6
Is nanotechnology a boon for oral drug delivery?纳米技术对口服药物递送是一项福音吗?
Drug Discov Today. 2014 Oct;19(10):1530-46. doi: 10.1016/j.drudis.2014.04.011. Epub 2014 Apr 28.
7
Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.固体脂质基质介导的纳米构建策略提高药物的口服生物利用度。
Expert Opin Drug Metab Toxicol. 2019 Jun;15(6):499-515. doi: 10.1080/17425255.2019.1621289. Epub 2019 May 29.
8
Nanotechnology-Based Biopolymeric Oral Delivery Platforms for Advanced Cancer Treatment.用于晚期癌症治疗的基于纳米技术的生物聚合物口服给药平台
Cancers (Basel). 2020 Feb 24;12(2):522. doi: 10.3390/cancers12020522.
9
Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.基于脂质的系统作为提高难溶性药物生物利用度的一种有前景的方法。
Acta Pharm. 2013 Dec;63(4):427-45. doi: 10.2478/acph-2013-0040.
10
Active Targeting of Drugs and Bioactive Molecules via Oral Administration by Ligand-Conjugated Lipidic Nanocarriers: Recent Advances.通过配体偶联脂质纳米载体经口服主动靶向药物和生物活性分子:最新进展。
AAPS PharmSciTech. 2018 Dec 18;20(1):15. doi: 10.1208/s12249-018-1262-2.

引用本文的文献

1
Therapies and delivery systems for diabetic wound care: current insights and future directions.糖尿病伤口护理的治疗方法与递送系统:当前见解与未来方向
Front Pharmacol. 2025 Jul 22;16:1628252. doi: 10.3389/fphar.2025.1628252. eCollection 2025.
2
An Experimental Design Approach for Producing Curcumin-Loaded Solid Lipid Nanoparticles.一种制备载姜黄素固体脂质纳米粒的实验设计方法。
Pharmaceuticals (Basel). 2025 Mar 27;18(4):470. doi: 10.3390/ph18040470.
3
Solid Lipid Nanoparticles for the Management of Hypertension: Advancements and Challenges.

本文引用的文献

1
Full factorial design for optimization, development and validation of HPLC method to determine valsartan in nanoparticles.用于优化、开发和验证测定纳米颗粒中缬沙坦的高效液相色谱法的全因子设计。
Saudi Pharm J. 2015 Oct;23(5):549-55. doi: 10.1016/j.jsps.2015.02.001. Epub 2015 Mar 3.
2
Insoluble drug delivery strategies: review of recent advances and business prospects.难溶性药物递送策略:近期进展与商业前景综述
Acta Pharm Sin B. 2015 Sep;5(5):442-53. doi: 10.1016/j.apsb.2015.07.003. Epub 2015 Aug 24.
3
Composite chitosan hydrogels for extended release of hydrophobic drugs.
用于高血压治疗的固体脂质纳米粒:进展与挑战
Curr Pharm Des. 2025;31(23):1823-1843. doi: 10.2174/0113816128337166241219081400.
4
Targeted Nano-Based Systems for the Anti-Obesity Agent's Delivery.靶向纳米系统用于递送抗肥胖药物。
Adv Exp Med Biol. 2024;1460:657-676. doi: 10.1007/978-3-031-63657-8_22.
5
Evaluation of Silybin Nanoparticles against Liver Damage in Murine Infection.水飞蓟宾纳米颗粒对小鼠感染性肝损伤的评估
Pharmaceutics. 2024 May 4;16(5):618. doi: 10.3390/pharmaceutics16050618.
6
Transdermal Drug Delivery Systems: A Focused Review of the Physical Methods of Permeation Enhancement.经皮给药系统:渗透促进物理方法的重点综述
Adv Pharm Bull. 2024 Mar;14(1):67-85. doi: 10.34172/apb.2024.018. Epub 2023 Oct 14.
7
Advances in Antitumor Effects Using Liposomal Citrinin in Induced Breast Cancer Model.利用脂质体桔霉素在诱导性乳腺癌模型中的抗肿瘤作用研究进展
Pharmaceutics. 2024 Jan 26;16(2):174. doi: 10.3390/pharmaceutics16020174.
8
Computational Amendment of Parenteral In Situ Forming Particulates' Characteristics: Design of Experiment and PBPK Physiological Modeling.肠胃外原位形成微粒特性的计算修正:实验设计与PBPK生理建模
Pharmaceutics. 2023 Oct 23;15(10):2513. doi: 10.3390/pharmaceutics15102513.
9
Nanoparticles-induced potential toxicity on human health: Applications, toxicity mechanisms, and evaluation models.纳米颗粒对人体健康的潜在毒性:应用、毒性机制及评估模型。
MedComm (2020). 2023 Jul 14;4(4):e327. doi: 10.1002/mco2.327. eCollection 2023 Aug.
10
Cefazolin-Loaded Double-Shelled Hollow Mesoporous Silica Nanoparticles/Polycaprolactone Nanofiber Composites: A Delivery Vehicle for Regenerative Purposes.载头孢唑林的双壳中空介孔二氧化硅纳米粒子/聚己内酯纳米纤维复合材料:一种用于再生目的的递送载体。
Adv Pharm Bull. 2023 Mar;13(2):328-338. doi: 10.34172/apb.2023.032. Epub 2022 Apr 5.
用于疏水性药物延长释放的复合壳聚糖水凝胶。
Carbohydr Polym. 2016 Jan 20;136:570-80. doi: 10.1016/j.carbpol.2015.09.072. Epub 2015 Sep 28.
4
Recent Advances in Dendrimer Research for Cardiovascular Diseases.用于心血管疾病的树枝状大分子研究的最新进展
Biomacromolecules. 2015 Sep 14;16(9):2588-98. doi: 10.1021/acs.biomac.5b00979. Epub 2015 Sep 1.
5
Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics.使用前体脂质体提高缬沙坦的口服生物利用度:设计、表征及体内药代动力学
Drug Dev Ind Pharm. 2015;41(12):2077-88. doi: 10.3109/03639045.2015.1075026. Epub 2015 Aug 17.
6
Mesoporous silica nanoparticles in target drug delivery system: A review.靶向给药系统中的介孔二氧化硅纳米粒子:综述
Int J Pharm Investig. 2015 Jul-Sep;5(3):124-33. doi: 10.4103/2230-973X.160844.
7
Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.非离子表面活性剂囊泡载体提高卡维地洛的口服生物利用度:富含胆盐的囊泡和载体表面电荷的影响。
Int J Nanomedicine. 2015 Jul 29;10:4797-813. doi: 10.2147/IJN.S84703. eCollection 2015.
8
Polymeric micelles for oral drug administration enabling locoregional and systemic treatments.用于口服给药的聚合物胶束,可实现局部和全身治疗。
Expert Opin Drug Deliv. 2015 Feb;12(2):297-318. doi: 10.1517/17425247.2015.960841. Epub 2014 Sep 17.
9
Controlled delivery of carvedilol nanosuspension from osmotic pump capsule: in vitro and in vivo evaluation.从渗透泵胶囊中控制释放卡维地洛纳米混悬液:体外和体内评价
Int J Pharm. 2014 Nov 20;475(1-2):496-503. doi: 10.1016/j.ijpharm.2014.09.008. Epub 2014 Sep 8.
10
Is nanotechnology a boon for oral drug delivery?纳米技术对口服药物递送是一项福音吗?
Drug Discov Today. 2014 Oct;19(10):1530-46. doi: 10.1016/j.drudis.2014.04.011. Epub 2014 Apr 28.